Celix Pharmaceuticals
  • Anmelden

  • Mein Konto
  • Angemeldet als:

  • filler@godaddy.com


  • Mein Konto
  • Abmelden

  • About us
  • Team
  • Products
  • Business Development
  • Sustainability
  • News
  • Careers
  • Contact us
  • Mehr
    • About us
    • Team
    • Products
    • Business Development
    • Sustainability
    • News
    • Careers
    • Contact us
Celix Pharmaceuticals

Angemeldet als:

filler@godaddy.com

  • About us
  • Team
  • Products
  • Business Development
  • Sustainability
  • News
  • Careers
  • Contact us

Konto


  • Mein Konto
  • Abmelden


  • Anmelden
  • Mein Konto

3rd Jan 2023

Celix Pharma announces the launch of Bexarotene soft-gel Capsules. 

Celix Pharma is pleased to announce the launch of Bexarotene 75mg soft-gel capsules in the UK. Bexarotene 75mg is available in a child-resistant, HDPE bottle pack containing 100 capsules. 


Bexarotene is a third-generation retinoid and is indicated for the treatment of advanced skin cancers called cutaneous T-cell lymphomas. Bexarotene works by slowing or stopping the growth of cancer cells (1,2,3). 


Commenting on this launch, Subir Kohli, Co-founder & CEO said, “We are excited to launch another product for the specialist hospital channel. Bexarotene is a niche, high-cost drug in the derma-oncology space and launching the first generic equivalent in the UK, with substantial savings to the NHS reaffirms our values of bringing high-quality, affordable, life-saving medicines into the UK.” 


Shantreddy, Co-founder & COO added, “As a suspension in soft-gel capsule, Bexarotene presents unique development and manufacturing challenges which we are glad to have overcome alongside our partner.”


Source:

1 https://bnf.nice.org.uk/drugs/bexarotene

2 https://www.cancerresearchuk.org/about-cancer/treatment/drugs/bexarotene 

3 https://medlineplus.gov/druginfo/meds/a608006.html

About Celix Pharma Ltd 

Celix Pharma is a London-based generic pharmaceutical company founded in 2020 with an overarching goal to bring high quality, affordable, generic medicines with a sustainable supply chain to the UK. Celix Pharma focuses on bridging gaps in the market by identifying product opportunities arising from complexities in development and/or manufacturing, addressing supply disruptions and future patent expiries with a portfolio spanning generics, value-added generics, and hospital specialty products. Celix Pharma’s business model is built around creating a commercially led, customer-focused organization supported with strategic partnerships in R&D and manufacturing. 


 For more information, visit www.celixpharma.com  

Follow us on Linkedin

Copyright © 2020 Celix Pharma Ltd.

Company No. 12474195 (Registered in England & Wales)

All Rights Reserved.

  • Privacy Policy

Unterstützt von

Cookie Policy

This website uses cookies. By continuing to use this site, you accept our use of cookies. Privacy Policy

Accept & Close